Added Value of Deep Sequencing Relative to Population Sequencing in Heavily Pre-Treated HIV-1-Infected Subjects.

OBJECTIVE: To explore the potential of deep HIV-1 sequencing for adding clinically relevant information relative to viral population sequencing in heavily pre-treated HIV-1-infected subjects. METHODS: In a proof-of-concept study, deep sequencing was compared to population sequencing in HIV-1-infected individuals with previous triple-class virological failure who also developed virologic failure to deep salvage therapy including, at least, darunavir, tipranavir, etravirine or raltegravir. Viral susceptibility was inferred before salvage therapy initiation and at virological failure using deep and population sequencing genotypes interpreted with the HIVdb, Rega and ANRS algorithms. The threshold level for mutant detection with deep sequencing was 1%. RESULTS: 7 subjects with previous exposure to a median of 15 antiretrovirals during a median of 13 years were included. Deep salvage therapy included darunavir, tipranavir, etravirine or raltegravir in 4, 2, 2 and 5 subjects, respectively. Self-reported treatment adherence was adequate in 4 and partial in 2; one individual underwent treatment interruption during follow-up. Deep sequencing detected all mutations found by population sequencing and identified additional resistance mutations in all but one individual, predominantly after virological failure to deep salvage therapy. Additional genotypic information led to consistent decreases in predicted susceptibility to etravirine, efavirenz, nucleoside reverse transcriptase inhibitors and indinavir in 2, 1, 2 and 1 subject, respectively. Deep sequencing data did not consistently modify the susceptibility predictions achieved with population sequencing for darunavir, tipranavir or raltegravir. CONCLUSIONS: In this subset of heavily pre-treated individuals, deep sequencing improved the assessment of genotypic resistance to etravirine, but did not consistently provide additional information on darunavir, tipranavir or raltegravir susceptibility. These data may inform the design of future studies addressing the clinical value of minority drug-resistant variants in treatment-experienced subjects.

Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil

Hepatitis C virus (HCV) is the major infectious disease agent among injecting drug users (IDUs), with seroprevalence ranging from 50-90%. In this paper, serological and virological parameters were investigated among 194 IDUs, 94 ex-IDUs and 95 non-IDUs that were sampled by the "snowball" technique in three localities renowned for both intense drug use and trafficking activities in Salvador, Brazil. The majority of the participants were male, but sex and mean age differed significantly between IDUs/ex-IDUs and non-IDUs (p < 0.05). Anti-HCV screening revealed that 35.6%, 29.8% and 5.3% of samples from IDUs, ex-IDUs and non-IDUs, respectively, were seropositive. HCV-RNA detection confirmed that the prevalence of infection was 29.4%, 21.3% and 5.3% for IDUs, ex-IDUs and non-IDUs, respectively. Genotyping analysis among IDUs/ex-IDUs determined that 76.9% were infected with genotype 1, 18.5% with genotype 3 and 4.6% with a mixed genotype; this result differed significantly from non-IDUs, where genotype 3 was the most frequent (60%), followed by genotype 1 (20%) and a mixed genotype (20%). We report a significantly higher prevalence of HCV infection in IDUs/ex-IDUs compared to the control group (p < 0.001). Although the sample size of our study was small, the differences in HCV genotype distribution reported herein for IDUs/ex-IDUs and non-IDUs warrant further investigation.

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.

BACKGROUND Antiretroviral treatment (ART) in children has special features and consequently, results obtained from clinical trials with antiretroviral drugs in adults may not be representative of children. Nelfinavir (NFV) is an HIV-1 Protease Inhibitor (PI) which has become as one of the first choices of PI for ART in children. We studied during a 3-year follow-up period the effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children. METHODS Forty-two vertically HIV-infected children on HAART with NFV were involved in a multicentre prospective study. The children were monitored at least every 3 months with physical examinations, and blood sample collection to measure viral load (VL) and CD4+ cell count. We performed a logistic regression analysis to determinate the odds ratio of baseline characteristics on therapeutic failure. RESULTS Very important increase in CD4+ was observed and VL decreased quickly and it remained low during the follow-up study. Children with CD4+ <25% at baseline achieved CD4+ >25% at 9 months of follow-up. HIV-infected children who achieved undetectable viral load (uVL) were less than 40% in each visit during follow-up. Nevertheless, HIV-infected children with VL >5000 copies/ml were less than 50% during the follow-up study. Only baseline VL was an important factor to predict VL control during follow-up. Virological failure at defined end-point was confirmed in 30/42 patients. Along the whole of follow-up, 16/42 children stopped HAART with NFV. Baseline characteristics were not associated with therapeutic change. CONCLUSION NFV is a safe drug with a good profile and able to achieve an adequate response in children.

I-SS: integrated supervision systems approach based on interactive components

Process supervision is the activity focused on monitoring the process operation in order to deduce conditions to maintain the normality including when faults are present Depending on the number/distribution/heterogeneity of variables, behaviour situations, sub-processes, etc. from processes, human operators and engineers do not easily manipulate the information. This leads to the necessity of automation of supervision activities. Nevertheless, the difficulty to deal with the information complicates the design and development of software applications. We present an approach called "integrated supervision systems". It proposes multiple supervisors coordination to supervise multiple sub-processes whose interactions permit one to supervise the global process

Disseny d’un programa que assisteix en la seqüenciació de peces de taller basats en mètodes heurístics

El GREP (grup de recerca de producte, procés i producció) de la UdG actualmentdisposa d’una eina informàtica desenvolupada en un PFC del 2003 que li permet fer la seqüenciació de la producció d’un taller mecànic amb un màxim de cinc productes, un nombre definit de possibles rutes de fabricació per a cada producte i tres màquines. Aquesta eina és molt resolutiva per a aquests casos, ja que estudia totes les possibilitats i les comprova una per una. No obstant aquest fet presenta una sèrie de limitacions com són el temps d’execució doncs al comprovar totes les seqüències té un elevat cost computacional i la rigidesa del sistema doncs no ens permet seqüenciar més productes ni més màquines. Per tal de donar solució a aquest problema es planteja generar una nova eina informàtica a partir de l’actual però que permeti seqüenciar més peces sense ocupar tanta memòria per així implementar-hi futures millores com el temps de preparació etc... Per a desenvolupar l’eina informàtica s’han utilitzat mètodes heurístics, concretament dos que són: algoritmes genètics i cerca TABU. Aquests mètodes destaquen perquè no busquen totes les combinacions possibles sinó que estudien una sèrie de combinacions i utilitzant mètodes de creuament i generació d’entorns busquen una solució

Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study.

BACKGROUND. Ritonavir-boosted saquinavir (SQVr) is nowadays regarded as an alternative antiretroviral drug probably due to several drawbacks, such as its high pill burden, twice daily dosing and the requirement of 200 mg ritonavir when given at the current standard 1000/100 mg bid dosing. Several once-daily SQVr dosing schemes have been studied with the 200 mg SQV old formulations, trying to overcome some of these disadvantages. SQV 500 mg strength tablets became available at the end of 2005, thus facilitating a once-daily regimen with fewer pills, although there is very limited experience with this formulation yet. METHODS. Prospective, multicentre study in which efficacy, safety and pharmacokinetics of a regimen of once-daily SQVr 1500/100 mg plus 2 NRTIs were evaluated under routine clinical care conditions in either antiretroviral-naïve patients or in those with no previous history of antiretroviral treatments and/or genotypic resistance tests suggesting SQV resistance. Plasma SQV trough levels were measured by HPLV-UV. RESULTS. Five hundred and fourteen caucasian patients were included (47.2% coinfected with hepatitis C and/or B virus; 7.8% with cirrhosis). Efficacy at 52 weeks (plasma RNA-HIV <50 copies/ml) was 67.7% (CI95: 63.6 - 71.7%) by intention-to-treat, and 92.2% (CI95: 89.8 - 94.6%) by on-treatment analysis. The reasons for failure were: dropout or loss to follow-up (18.4%), virological failure (7.8%), adverse events (3.1%), and other reasons (4.6%). The high rate of dropout may be explained by an enrollment and follow-up under routine clinical care condition, and a population with a significant number of drug users. The median SQV Cmin (n = 49) was 295 ng/ml (range, 53-2172). The only variable associated with virological failure in the multivariate analysis was adherence (OR: 3.36; CI95, 1.51-7.46, p = 0.003). CONCLUSIONS. Our results suggests that SQVr (1500/100 mg) once-daily plus 2 NRTIs is an effective regimen, without severe clinical adverse events or hepatotoxicity, scarce lipid changes, and no interactions with methadone. All these factors and its once-daily administration suggest this regimen as an appropriate option in patients with no SQV resistance-associated mutations.

Aplicatiu de gestió de magatzem amb dispositiu mòbils de Materials Brecor

Disseny d’un projecte que controli la gestió d’ubicacions del magatzem d’una empresa del sector de materials de construcció, concretament de “Materials Brecor”, una empresa líder de la zona compresa entre la costa brava sud i el maresme nord. L’Objectiu principal és concebre un projecte que permeti controlar en temps real tant l’entrada com la sortida de mercaderies, a més a més de poder consultar la ubicació de cadascuna d’elles dins el magatzem. Aconseguint millorar els temps de resposta en el moment de localitzar l’article demanat i la seva posterior expedició al client

Automatització d’una màquina de tall rotatiu

Molt sovint, a l’indústria de l’alimentació o de la cosmètica, hi ha promocions on s’afegeixen productes de regal; aquests els embalen amb un sleever (tipus de plàstic força rígid) que després retractilen. Aquestes promocions solen ser esporàdiques i canviants i això fa que no sigui factible la modificació de la línia de producció general per a realitzar-les. Per aquest motiu, moltes empreses disposen d’una petita màquina de tall rotatiu per a poder tallar els sleevers ells mateixos, i així tallar a molta velocitat i precisió aquestes petites produccions. Així doncs, esdevé molt interessant l’adquisició d’aquest tipus de maquinària. L’objectiu del projecte és fer l’automatització d’una màquina que pugui tallar aquest tipus de material ràpidament per fer-lo rentable

Influence of GB virus C on IFN-γ and IL-2 production and CD38 expression in T lymphocytes from chronically HIV-infected and HIV-HCV-co-infected patients

This study was designed to assess the effect of GB virus (GBV)-C on the immune response to human immunodeficiency virus (HIV) in chronically HIV-infected and HIV- hepatitis C virus (HCV)-co-infected patients undergoing antiretroviral therapy. A cohort of 159 HIV-seropositive patients, of whom 52 were HCV-co-infected, was included. Epidemiological data were collected and virological and immunological markers, including the production of interferon gamma (IFN-γ) and interleukin (IL)-2 by CD4, CD8 and Tγδ cells and the expression of the activation marker, CD38, were assessed. A total of 65 patients (40.8%) presented markers of GBV-C infection. The presence of GBV-C did not influence HIV and HCV replication or TCD4 and TCD8 cell counts. Immune responses, defined by IFN-γ and IL-2 production and CD38 expression did not differ among the groups. Our results suggest that neither GBV-C viremia nor the presence of E2 antibodies influence HIV and HCV viral replication or CD4 T cell counts in chronically infected patients. Furthermore, GBV-C did not influence cytokine production or CD38-driven immune activation among these patients. Although our results do not exclude a protective effect of GBV-C in early HIV disease, they demonstrate that this effect may not be present in chronically infected patients, who represent the majority of patients in outpatient clinics.

Influence of IL28B polymorphisms on response to a lower-than-standard dose peg-IFN-α 2a for genotype 3 chronic hepatitis C in HIV-coinfected patients.

BACKGROUND Data on which to base definitive recommendations on the doses and duration of therapy for genotype 3 HCV/HIV-coinfected patients are scarce. We evaluated the efficacy of a lower peginterferon-α 2a dose and a shorter duration of therapy than the current standard of care in genotype 3 HCV/HIV-coinfected patients. METHODS AND FINDINGS Pilot, open-label, single arm clinical trial which involved 58 Caucasian HCV/HIV-coinfected patients who received weekly 135 µg peginterferon-α 2a plus ribavirin 400 mg twice daily during 20 weeks after attaining undetectable viremia. The relationships between baseline patient-related variables, including IL28B genotype, plasma HCV-RNA, ribavirin dose/kg, peginterferon-α 2a and ribavirin levels with virological responses were analyzed. Only 4 patients showed lack of response and 5 patients dropped out due to adverse events related to the study medication. Overall, sustained virologic response (SVR) rates were 58.3% by intention-to-treat and 71.4% by per protocol analysis, respectively. Among patients with rapid virologic response (RVR), SVR and relapses rates were 92.6% and 7.4%, respectively. No relationships were observed between viral responses and ribavirin dose/kg, peginterferon-α 2a concentrations, ribavirin levels or rs129679860 genotype. CONCLUSIONS Weekly 135 µg pegIFN-α 2a could be as effective as the standard 180 µg dose, with a very low incidence of severe adverse events. A 24-week treatment duration appears to be appropriate in patients achieving RVR, but extending treatment up to just 20 weeks beyond negativization of viremia is associated with a high relapse rate in those patients not achieving RVR. There was no influence of IL28B genotype on the virological responses.

Automatització d'una planta de preparació i distribució de pinsos

La finalitat del projecte és realitzar l’automatització dels sis processos d’una fàbrica de pinsos d’una cooperativa agrícola: entrada de matèries, mòlta, dosificació amb correcció, barreja, granulació i sortida de pinsos.Per controlar tots els processos es desenvolupa un PLC amb el corresponent programa d’autòmat; se seleccionen els diferents sensors i preactivadors necessaris que s’hauran d’incorporar per poder transformar la lògica rígida de contactors a una de flexible; se selecciona un sistema Scada per a la interfície d’usuari, i es dissenya la instal·lació elèctrica corresponent, per tal de poder implementar aquest automatisme en la línia de producció

Automatització d'una planta de tractament d'aigua potable

Estudi sobre l'automatització d’unaplanta de tractament d’aigua potable. Es mantindran els equips existents i les seqüències de treball que regeixen actualment el treball de la planta. Es limitaran les accions directes delsoperaris, els quals tindran com a funció la supervisió del correcte funcionament de la planta intervenint en cas d’eventuals anomalies. Es vol aconseguir una millora en la gestió i els resultats del funcionament de la planta

Instal·lacions d'una nau magatzem per a un club de golf i automatització del seu reg

El projecte efectua la descripció i càlcul de les instal·lacions d'una nau magatzem per a un club de golf, així com l’automatització del reg i adobament de la gespa per tal d’optimitzar els recursos hídrics. La part de les instal·lacions s’ha separat en cinc blocs en els quals s’ha efectuat una descripció de les característiques de les diferents instal·lacions, el càlcul de línies elèctriques, dimensionament dels equips, col·lectors i distàncies, complint els objectius inicials i la reglamentació vigent. Pel que fa l’automatització del procés, s’han complert els objectius d’optimitzar els recursos hídrics de què disposava el club, aprofitant al màxim les aigües pluvials recollides i permetent la fertilització de la gespa, de manera homogènia a tot el camp

Diagnosi basada en models tenint en compte els retards en xarxes de comunicació

Els mètodes de detecció, diagnosi i aïllament de fallades (Fault Detection and Isolation - FDI) basats en la redundància analítica (és a dir, la comparació del comportament actual del procés amb l’esperat, obtingut mitjançant un model matemàtic del mateix), són àmpliament utilitzats per al diagnòstic de sistemes quan el model matemàtic està disponible. S’ha implementat un algoritme per implementar aquesta redundància analítica a partir del model de la plana conegut com a Anàlisi Estructural